BBSI Reports Strong Fourth Quarter and Full Year 2024 Financial Results

(NASDAQ:BBSI), – Fourth Quarter Revenues up 10% to $304.8 Million With Net Income up 15% to $16.8 Million, or $0.63 per Diluted Share – VANCOUVER, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (“BBSI” or the “Company”) (NASDAQ: BBSI), a leading provider of business management solutions, reported financial results for the fourth […]

Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference

(NASDAQ:ANNX), BRISBANE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that Douglas Love, president and chief executive officer, will present at the TD Cowen

Adventure Box Enters Into a LOI for Acquisition and Strategic Expansion With Blok Sports and Sparx Technologies

(Nasdaq First North Sweden:ADVBOX),(Nasdaq First North Sweden:ADVBOX.ST), As Previously Announced on February 8, 2025 STOCKHOLM, Feb. 26, 2025 (GLOBE NEWSWIRE) — Adventure Box Technology AB (STO: ADVBOX) Adventure Box Technologies AB (publ) (“Adventure Box” or “the Company”) announced on February 8, 2025, the execution of a Letter of Intent to purchase 100% of Blok Sports

Remitly Announces Upcoming Investor Conference Participation

(NASDAQ:RELY), SEATTLE, Feb. 26, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that its management team will present at the following investor conferences: The Citizens JMP Technology ConferenceDate: Tuesday, March 4, 2025Time: 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time

Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

(NASDAQ:AMBA), SANTA CLARA, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced fourth quarter and full year fiscal 2025 financial results for the period ended January 31, 2025. Revenue for the fourth quarter of fiscal 2025 was $84.0 million, up 62.8% from $51.6 million in the

Pool Corporation Declares Quarterly Cash Dividend

(NASDAQ:POOL), COVINGTON, La., Feb. 26, 2025 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq/GSM:POOL) announced today that its Board of Directors declared a quarterly cash dividend of $1.20 per share. The dividend will be payable on March 26, 2025, to holders of record on March 12, 2025. POOLCORP is the world's largest wholesale distributor of swimming pool

Lightbridge Provides Business Update and Announces Fiscal Year 2024 Financial Results

(NASDAQ:LTBR), RESTON, Va., Feb. 26, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2024, and provided an update on the Company's continued progress. Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented,

FutureFuel Earns Bronze Medal from EcoVadis for Sustainability Performance

(NYSE:FF), CLAYTON, Mo., Feb. 26, 2025 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it has been awarded a Bronze Medal for sustainability performance by EcoVadis, a leading third-party assessor of Environmental, Social, and Governance (ESG) performance. This achievement underscores FutureFuel's commitment to

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

(NASDAQ:ALEC), Topline data from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN expected by Q4 2025 Anticipate completing enrollment in the PROGRESS-AD Phase 2 clinical trial of AL101/GSK4527226 in participants with early Alzheimer's disease by mid-2025 Applying Alector Brain Carrier to advance therapeutic candidates, including those targeting amyloid beta and replacing GCase

Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

(NASDAQ:LFCR), CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore's participation are as follows: TD Cowen 45th Annual Health Care ConferenceDetails: Paul Josephs,

Scroll to Top